PlGF-based testing can help with clinical risk stratification for women with suspected pre-eclampsia, meaning they can be treated appropriately according to their need, improving both patient experience and outcomes and improving the use of scarce system resources.
This programme was selected for adoption and spread through the AHSN Network as a Rapid Uptake Product by the Accelerated Access Collaborative and the Innovation and Technology Payment (ITP).
Get in touch
If you want to learn more about the rollout of this intervention in the east please contact [email protected].
Find out more
Impact review
Read more about PlGF testing, including how we are working to adopt and spread this work across the east in our latest impact review.